NSF Webcast: Getting a Grip on Stroke Treatment
Innovators present new device for removing blood clots in the brain
View a webcast featuring the SHELTER technology and its developers Vikram and Vallabh Janardhan.
A new surgical device--tested using silicone copies of human cadaver blood vessels--is poised to advance stroke treatment and revolutionize how the medical community evaluates new technologies.
On Thursday, May 27, at 2:00 p.m. EDT, during a webcast hosted by the National Science Foundation, the developers of the net-like Insera SHELTERTM device will demonstrate how their technology filters and removes blood clots, and present the latest results from recent performance tests.
Interventional neurologist Vallabh Janardhan and Insera engineer and CEO Vikram Janardhan will explain how SHELTERTM (which stands for Stroke Help using an Endo-Luminal Transcatheter Embolus Retrieval device) may be a safer alternative to the common "corkscrew" approach for strokes, which can release stroke-inducing debris. The researchers will also describe their uniquely accurate testing platform, one nearly identical to living human tissues--complete with aneurisms, atherosclerosis and "plaque"--which may supplant certain types of animal testing experiments.
Questions before and during the webcast can be directed to email@example.com. May is National Stroke Awareness Month; learn more on the Centers for Disease Control and Prevention website. Insera is supported by NSF SBIR grant 0946099.
The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2016, its budget is $7.5 billion. NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and other institutions. Each year, NSF receives more than 48,000 competitive proposals for funding and makes about 12,000 new funding awards. NSF also awards about $626 million in professional and service contracts yearly.
Useful NSF Web Sites: